Abstract
A VARIETY of mechanisms underlie the pharmacological blockade of membrane excitability. Some drugs seem to reduce the frequency at which ion channels open; a good example is the effect of curare on acetylcholine receptor channels at normal resting potentials. Another sort of mechanism may account for the action of many local anaesthetics and related drugs containing charged ammonium groups. It is postulated that such molecules block transmembrane currents as they bind to sites within open ion channels, much like a plug in a drain, with the important difference that the events occur on a millisecond time scale. This model, which we shall call ‘open-channel blockade’, was first applied to the effect of internal tetraethylammonium ions on K+ channels in squid axon1 and more recently to similar actions of local anaesthetics on acetylcholine receptor channels2–4 and on electrically excitable Na+ channels5. (Curare seems to exert an additional open-channel blockade at high negative potentials6,7.) The concept of open-channel blockade would receive direct experimental support from the demonstration that the blockade is exerted even if the blocking molecule is not bound to the channel (or indeed is not present at all) until after the channel opens. Such a demonstration is made possible by a drug that (1) blocks acetylcholine receptor channels in Electrophorus electroplaque, and (2) is created, in less than a millisecond, by a flash of light.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Armstrong, C. M. J. gen. Physiol. 50, 491–503 (1966).
Steinbach, A. B. J. gen. Physiol. 52, 144–161 (1968).
Steinbach, A. B. J. gen. Physiol. 52, 162–180 (1968).
Adams, P. R. J. Physiol., Lond., 246, 61–63P (1975).
Strichartz, G. R. J. gen. Physiol. 62, 37–57 (1973).
Katz, B. & Miledi, R. Proc. R. Soc. B203, 119–133 (1978).
Colquhoun, D., Dreyer, F. & Sheridan, R. E. J. Physiol., Lond. (in the press).
Bieth, J., Wassermann, D., Vratsanos, S. M. & Erlanger, B. F. Proc. natn. Acad. Sci. U.S.A. 66, 850–854 (1970).
Sheridan, R. E. & Lester, H. A. Proc. natn. Acad. Sci. U.S.A. 72, 3496–3500 (1975).
Sheridan, R. E. & Lester, H. A. J. gen. Physiol. 70, 187–219 (1977).
Lester, H. A., Koblin, D. D. & Sheridan, R. E. Biophys. J. 21, 181–194 (1978).
Furukawa, T. Jap. J. Physiol. 7, 199–212 (1957).
Lester, H. A., Changeux, J.-P. & Sheridan, R. E. J. gen. Physiol. 65, 797–816 (1975).
Beam, K. G. J. Physiol., Lond. 258, 279–300 (1976).
Adams, P. R. J. Physiol., Lond. 268, 291–318 (1977).
Neher, E. & Steinbach, J. H. J. Physiol., Lond. 277, 153–176 (1978).
Koblin, D. D. & Lester, H. A. Molec. Pharmac. (in the press).
Nass, M. M., Lester, H. A. & Krouse, M. E. Biophys. J. 24, 135–160 (1978).
Magleby, K. L. & Stevens, C. F. J. Physiol., Lond. 223, 151–171 (1972).
Magleby, K. L. & Stevens, C. F. J. Physiol., Lond. 223, 173–197 (1972).
Anderson, C. R. & Stevens, C. F. J. Physiol., Lond. 235, 655–691 (1973).
Wathey, J. C., Nass, M. M. & Lester, H. A. Biophys. J. 27, 145–164 (1979).
Katz, B. & Miledi, R. J. Physiol., Lond. 230, 707–717 (1973).
Rosenberry, T. in Adv. Enzymol. 43, 103–218 (1975).
Deal, W. J., Erlanger, B. F. & Nachmansohn, D. Proc. natn. Acad. Sci. U.S.A. 64, 1230–1234 (1969).
Bartels, E., Wassermann, N. H. & Erlanger, B. F. Proc. natn. Acad. Sci. U.S.A. 68, 1820–1823 (1971).
Erlanger, B. F. A. Rev. Biochem. 45, 267–283 (1976).
Lester, H. A. & Chang, H. W. Nature 266, 373–374 (1977).
Wassermann, N. H., Bartels, E. & Erlanger, B. F. Proc. natn. Acad. Sci. U.S.A. 76, 256–259 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
LESTER, H., KROUSE, M., NASS, M. et al. Light-activated drug confirms a mechanism of ion channel blockade. Nature 280, 509–510 (1979). https://doi.org/10.1038/280509a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/280509a0
This article is cited by
-
Optical control of purinergic signaling
Purinergic Signalling (2021)
-
Cloaked caged glutamate eliminates off-target GABA-A receptor antagonism and opens a new door in neuroscience
Lab Animal (2020)
-
Optical control of neuronal ion channels and receptors
Nature Reviews Neuroscience (2019)
-
Block of acetylcholine-activated ion channels by an uncharged local anaesthetic
Nature (1981)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.